Chandra SK, Ramesh G (2013) The fourth-generation calcium channel blocker cilnidipine. Ind. Heart J 65:691–695. https://doi.org/10.1016/j.ihj.2013.11.001
Article
Google Scholar
Yoshimoto R, Dohmoto H, Yamala K, Goto A (1991) Prolonged inhibition of vascular contraction and calcium influx by the novel 1, 4 dihydropyridine calcium antagonist cilnidipine (FRC-8653). Japan J Pharmacol l56:225–229
Article
Google Scholar
Neil O (2006) The Merck index an encyclopedia of chemical and biological, vol 48, 14th edn. Merck & Co. Inc, p 379
Google Scholar
Nadeem S, Asif H, Lakshita C, Shamsher A, Moloy M, Parminder SB (2011) Pharmacological and pharmaceutical profile of valsartan: a review. J Appl Pharm Sci 01(04):12–19
Google Scholar
Goodman and Gilman’s (2001) The pharmacology basis of therapeutics. Medical publishing Division, New York, pp 249–260
Google Scholar
Shinji T, Denan J, Shizuka A, Kazumi N, Mizuo M (2013) Powerful vascular protection by combining cilnidipine with valsartan in stroke-prone, spontaneously hypertensive rats. Hypert Rese 36:342–348
Article
CAS
Google Scholar
Jieon L, Howard L, Kyungho J, Kyoung SL, Dongseong S, Kyung S-Y (2014) Evaluation of the pharmacokinetic and pharmacodynamic drug interactions between cilnidipine and valsartan, in healthy volunteers. Drug Design Devel Ther 8:1781–1788
Google Scholar
Heon WL, Ji-Hyung S, Hyun-Su L, Seo-Young J, Young-WC, Kyung-Tae L (2008) Development of a liquid chromatography/negative-ion electrospray tandem mass spectrometry assay for the determination of cilnidipine in human plasma and its application to a bioequivalence study. J Chromatogr B 862:246–251
Article
CAS
Google Scholar
Xianhua Z, Suodi Z, Rongsheng Z, Jin O, Li X, Willy RG (2007) Determination of cilnidipine, a new calcium antagonist, in human plasma using high-performance liquid chromatography with tandem mass spectrometric. Anal Chim Acta 600:142–146
Article
CAS
Google Scholar
Alagar R, Ashwini David B, Rao KN, Selva K (2015) A new analytical method development and validation for the estimation of olmesartan medoxomil and cilnidipine in its pharmaceutical dosage form by UPLC as per ICH guidelines D2. Asian J Rese Bio Pharm Sci 3(2):78–86
Google Scholar
Amit SM, Manjusha ND, Sanjay DS (2014) Development and validation of an analytical method for simultaneous estimation of cilnidipine and olmesartan medoxomil in bulk and tablet dosage form by RP-HPLC. Int J Pharm Pharm Sci 7(6):508–511
Google Scholar
Krishnaiah CH, Reddy RA, Ramesh K, Mukkanti K (2015) Stability-indicating UPLC method for determination of valsartan and their degradation products in active pharmaceutical ingredient and pharmaceutical dosage forms. J Pharm Biomed Anal 53:483–489
Article
CAS
Google Scholar
Jirí V (2015) A new, rapid, stability-indicating UPLC method for separation and determination of impurities in amlodipine besylate, valsartan, and hydrochlorothiazide in their combined tablet dosage form. J Pharm Biomed Anal 109:36–44
Article
CAS
Google Scholar
Vishal G, Rajeshwari R, Ranjeet P, Dash MN (2013) Simultaneous quantification of aliskiren, valsartan and sitagliptin by LC with fluorescence detection: evidence of pharmacokinetic interaction in rats. Chromatographia 76(9-10):515–521
Article
CAS
Google Scholar
Rasha A, Shaalan TS, Belal FA, El Y, Sohila M (2013) Validated stability-indicating HPLC-DAD method of analysis for the antihypertensive triple mixture of amlodipine besylate, valsartan and hydrochlorothiazide in their tablets. Arab J Chem 10(1):S1381–S1394
Google Scholar
Hiten JS, Naresh B, Kataria GS, Chagan NP (2009) Simultaneous LC-MS-MS analysis of valsartan and hydrochlorothiazide in human plasma. Chromatographia 69(9-10):1055–1060
Article
CAS
Google Scholar
Nozomu K, Hiroto K (2007) Development and validation of a method for the quantitative determination of valsartan in human plasma by liquid chromatography-tandem mass spectrometry. J Pharm Biomed Anal 43:1769–1774
Article
CAS
Google Scholar
Senthamil SP, Veeran GK, Mandal U, Sam-Solomon WD, Pal TK (2007) Simultaneous determination of fixed-dose combination of nebivolol and valsartan in human plasma by liquid chromatographic-tandem mass spectrometry and its application to a pharmacokinetic study. J Chromatogr B 858(1-2):143–150
Article
CAS
Google Scholar
Shankar GG, Pragney D, Madhusudana K, Ramakrishna S (2014) Simultaneous determination of amlodipine, valsartan, and hydrochlorothiazide by LC–ESI-MS/MS and its application to pharmacokinetics in rats. J of Pharm Ana 6(4):399–406
Google Scholar
del RB M (2009) Determination of losartan, Telmisartan, and valsartan by direct injection of human urine into a column-switching liquid chromatographic system with fluorescence detection. J Pharm Biomed Anal 50:194–199
Article
CAS
Google Scholar
U. S .Department of Health and Human Services (2013) Food and Drug Administration: guidance for industry, bioanalytical method validation, September
Google Scholar
Eboka MB, Sabi M, Janvier EA, Run Z, Li Q, Li D (2016) Simultaneous determination of a fixed-dose combination of lercanidipine and valsartan in human plasma by LC-MS-MS: application to a pharmacokinetic study. J Chromatogr Sci 54(9):1553–1559
Article
CAS
Google Scholar
Aruna G, Bharathi K, Prasad K (2017) Development and validation of bioanalytical HPLC method for simultaneous estimation of clinidipine and nebivolol in human plasma. Int J Pharm Pharm Sci 9(10):253–259
CAS
Google Scholar
Mir-Ali F, Parisa K, Azar P (2016) Simultaneous determination of atorvastatin and valsartan in human plasma by solid- based disperser liquid-liquid microextraction followed by high-performance liquid chromatography-diode array detection. J Chromatogr B 1017:62–69
Google Scholar
Jiezhao Z, Meilling C, Li Y, Yu F, Xiaohui C, Hui ZXM (2017) Simultaneous determination of metolazone and valsartan in plasma by on-line SPEcoupled with liquid chromatography/tandem mass spectrometry. Eur J of Mass Spect 23(5):305–312
Article
CAS
Google Scholar
Jaldeepsinh VR, Maheshwari DG (2015) Development and validation of second order derivative spectrophotometric method for simultaneous estimation of cilnidipine and valsartan in synthetic mixture. Ame J of Pharm Tech Res 2(5):313–323
Google Scholar
Bhole RP, Pawara VC, Chitlange SS (2015) Development and validation of HPLC method for simultaneous estimation of cilnidipine and valsartan in bulk and tablet dosage form. Res & Re J of Pharm Sci 6(2):28–36
CAS
Google Scholar
Pooja JP, Ankit BC, Vijay PJ, Ruchi PS (2017) Stability indicating RP-HPLC method development and validation for estimation of cilnidipine and valsartan. World J Pharm Pharm Sci 5(5):1231–1245
Google Scholar
Bhoomi DA, Aniket B, Chaudhary PJ, Parmar VN (2016) Development and validation of reverse-phase high-performance liquid chromatography method for simultaneous estimation of nebivolol HCl and clinidipine in combined tablet dosage form. Pharm & Biom Eva 3(2):208–214
Google Scholar
Pavan KV, Lokeswara G, Haribaskar V, Gobinath M (2015) Development and validation of RP-HPLC method for simultaneous estimation of metoprolol succinate and cilnidipine in combined tablet dosage form. Int J Pharm 5(4):1196–1202
CAS
Google Scholar
Priyanka RP, Nilam P, Samir KS (2015) Analytical method development and validation for simultaneous estimation of nebivolol hydrochloride and cilnidipine in the combined dosage form. J Chem Pharm Res 7(9):951–960
Google Scholar
Ritesh PB, Vinayak CP, Sohan SC, Sager BW (2015) Development and validation of HPLC method for simultaneous estimation of cilnidipine and valsartan in bulk and tablet dosage form. Int J of Pharm Chem Ana 2(1):102–107
Google Scholar
Sunitha N, Subhash CM, Sai SJ, Venu A, Narasimha BV, Appa B (2015) Method development and validation of RP-HPLC method for the simultaneous estimation of olmesartan and cilnidipine in bulk and formulations. Int J of Pharm Res & Allied Sci 4(3):127–135
CAS
Google Scholar